# Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative Colitis

> **NCT02093663** · PHASE3 · COMPLETED · sponsor: **Shire** · enrollment: 107 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** MMX Mesalamine/Mesalazine (Low Dose)
- **DRUG:** MMX Mesalamine/Mesalazine (High Dose)

## Key facts

- **NCT ID:** NCT02093663
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12-12
- **Primary completion:** 2018-11-28
- **Final completion:** 2018-11-28
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2021-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02093663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02093663, "Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative Colitis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02093663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*